Search details
1.
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Biol Blood Marrow Transplant
; 25(4): 625-638, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30592986
2.
Treatment patterns and medication adherence among patients diagnosed with multiple myeloma and treated with panobinostat.
Future Oncol
; 14(21): 2149-2160, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-29846095
3.
Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant
; 21(12): 2154-2159, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26327632
4.
False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapy.
Blood
; 131(23): 2596-2598, 2018 06 07.
Article
in English
| MEDLINE | ID: mdl-29669777
5.
Vitamin D effect on umbilical cord blood characteristics: a comparison between African Americans and Caucasians.
Transfusion
; 55(7): 1766-71, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25903156
6.
Rare form of autosomal dominant thalassemia--hemoglobin Hakkari.
Pediatr Blood Cancer
; 61(11): 2118-20, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-24789613
7.
Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropenia.
Curr Opin Hematol
; 19(1): 21-6, 2012 Jan.
Article
in English
| MEDLINE | ID: mdl-22080847
8.
Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.
Biol Blood Marrow Transplant
; 18(12): 1776-84, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-22863842
9.
An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.
Blood
; 116(19): 3999-4006, 2010 Nov 11.
Article
in English
| MEDLINE | ID: mdl-20587781
10.
Characteristics of thawed autologous umbilical cord blood.
Transfusion
; 52(10): 2234-42, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22321210
11.
Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy.
Blood Adv
; 5(2): 593-601, 2021 01 26.
Article
in English
| MEDLINE | ID: mdl-33496754
12.
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.
J Immunother Cancer
; 9(8)2021 08.
Article
in English
| MEDLINE | ID: mdl-34353848
13.
A novel ELANE gene mutation in a patient with severe congenital neutropenia and intermittent thrombocytopenia.
Pediatr Blood Cancer
; 62(10): 1870-1, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-25882539
14.
Economic Burden of Neurologic Toxicities Associated with Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United States.
Am Health Drug Benefits
; 13(5): 192-199, 2020.
Article
in English
| MEDLINE | ID: mdl-33343819
15.
GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas.
Am J Cancer Res
; 10(2): 674-687, 2020.
Article
in English
| MEDLINE | ID: mdl-32195035
16.
Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia.
Int J Hematol
; 111(2): 303-310, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31709501
17.
Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy.
Curr Hematol Malig Rep
; 14(1): 47-55, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30666506
18.
Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma.
Leuk Lymphoma
; 59(5): 1133-1142, 2018 05.
Article
in English
| MEDLINE | ID: mdl-28933643
Results
1 -
18
de 18
1
Next >
>>